JP Morgan Chase
AHCO icon

JP Morgan Chase’s AdaptHealth AHCO Stock Holding History

JP Morgan Chase’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Sell
131,152
-43,573
-25% -$486K ﹤0.01% 4456
2026
Q1 		$1.97M Sell
174,725
-7,579
-4% -$77.6K ﹤0.01% 4112
2025
Q4 		$1.82M Sell
182,304
-17,837
-9% -$170K ﹤0.01% 4145
2025
Q3 		$1.79M Sell
200,141
-11,628
-5% -$108K ﹤0.01% 4163
2025
Q2 		$2M Buy
211,769
+2,718
+1% +$24K ﹤0.01% 3923
2025
Q1 		$2.27M Buy
209,051
+16,650
+9% +$168K ﹤0.01% 3784
2024
Q4 		$1.83M Buy
192,401
+568
+0.3% +$5.75K ﹤0.01% 4220
2024
Q3 		$2.15M Buy
191,833
+81,097
+73% +$862K ﹤0.01% 3949
2024
Q2 		$1.11M Sell
110,736
-228,082
-67% -$2.32M ﹤0.01% 4207
2024
Q1 		$3.9M Buy
338,818
+176,592
+109% +$1.5M ﹤0.01% 3310
2023
Q4 		$1.18M Sell
162,226
-552,255
-77% -$4.35M ﹤0.01% 4218
2023
Q3 		$6.5M Sell
714,481
-28,633
-4% -$343K ﹤0.01% 2637
2023
Q2 		$9.04M Sell
743,114
-356,836
-32% -$3.98M ﹤0.01% 2367
2023
Q1 		$13.7M Sell
1,099,950
-166,886
-13% -$3.07M ﹤0.01% 1987
2022
Q4 		$24.3M Sell
1,266,836
-18,440
-1% -$390K ﹤0.01% 1520
2022
Q3 		$24.1M Buy
1,285,276
+440,722
+52% +$9.06M ﹤0.01% 1456
2022
Q2 		$15.2M Buy
844,554
+400,622
+90% +$6.5M ﹤0.01% 1848
2022
Q1 		$7.12M Sell
443,932
-345,881
-44% -$6.22M ﹤0.01% 2698
2021
Q4 		$19.3M Sell
789,813
-29,769
-4% -$699K ﹤0.01% 1852
2021
Q3 		$19.1M Sell
819,582
-59,100
-7% -$1.43M ﹤0.01% 1807
2021
Q2 		$24.1M Sell
878,682
-76,817
-8% -$2.19M ﹤0.01% 1685
2021
Q1 		$35.1M Buy
955,499
+243,494
+34% +$8.6M ﹤0.01% 1340
2020
Q4 		$26.7M Buy
712,005
+696,679
+4,546% +$21.6M ﹤0.01% 1416
2020
Q3 		$324K Buy
15,326
+8,971
+141% +$188K ﹤0.01% 4167
2020
Q2 		$102K Buy
+6,355
New +$106K ﹤0.01% 4556

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase's AHCO Position: Q2 2026 in Review

JP Morgan Chase reduced its AdaptHealth (AHCO) stake by 25% in Q2 2026, selling an estimated $486K and leaving 131,152 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #4456.

JP Morgan Chase first reported a position in AHCO in Q2 2020 and has held it in 25 quarters since. The position peaked at $35.1M in Q1 2021. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • JP Morgan Chase held 131,152 shares of AdaptHealth worth $1.38M as of Q2 2026.
  • JP Morgan Chase sold 43,573 AdaptHealth shares in Q2 2026, an estimated $486K.
  • AdaptHealth made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4456 holding.
  • JP Morgan Chase first reported a position in AdaptHealth in Q2 2020 and has held it in 25 quarters since.
  • JP Morgan Chase's AdaptHealth position peaked at $35.1M in Q1 2021.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.